Centene Corporation
CNC · NYSE · Healthcare · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$174.6B
Net margin
-3.8%
ROE
-33.4%
Revenue CAGR (2y)
+11.6%
EPS (FY2025)
-13.53
Net profit (FY2025)
$-6.7B
Ask MarketChacha about CNC
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Sep 2, 2026
Centene shares rose on continued positive momentum from its strong Q2 2026 results and raised full-year 2026 EPS and revenue guidance, supported by recent analyst upgrades and institutional buying interest.
- Jul 23, 2026
Centene shares fell with the broader market or healthcare sector, as no company-specific news, earnings, or filing was released today ahead of the scheduled Q2 report on July 28.
· confidence: low
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $174.6B | $-6.7B | -13.53 | -3.8% | -33.4% |
| FY2024 | $145.5B | $3.3B | 6.31 | 2.3% | 12.5% |
| FY2023 | $140.1B | $2.7B | 4.95 | 1.9% | 10.5% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $44.4B | $1.1B | 2.19 | 2.5% |
| 2026Q1 | $44.7B | $1.5B | 3.11 | 3.5% |
| 2025Q3 | $44.9B | $-6.6B | -13.50 | -14.8% |
| 2025Q2 | $42.5B | $-253.0M | -0.51 | -0.6% |
| 2025Q1 | $42.5B | $1.3B | 2.63 | 3.1% |
| 2024Q3 | $36.9B | $713.0M | 1.36 | 1.9% |
| 2024Q2 | $36.0B | $1.1B | 2.16 | 3.2% |
| 2024Q1 | $36.3B | $1.2B | 2.16 | 3.2% |
| 2023Q3 | $35.0B | $469.0M | 0.87 | 1.3% |
| 2023Q2 | $34.8B | $1.1B | 1.92 | 3.0% |
| 2023Q1 | $35.0B | $1.1B | 2.04 | 3.2% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC7/29/2026material
- SEC7/28/2026
- SEC6/22/2026material
- SEC5/15/2026material
- SEC4/28/2026
- SEC4/28/2026material
- SEC3/24/2026material
- SEC3/10/2026material
- SEC2/23/2026material
- SEC2/17/2026
- SEC2/6/2026material
2025
- SEC11/10/2025material
- SEC10/29/2025
- SEC10/29/2025material
- SEC9/11/2025material
- SEC8/15/2025material
- SEC8/4/2025material
- SEC7/25/2025
- SEC7/25/2025material
In the news
- Centene Corp. stock holds steady as valuation and growth outlook draw attentionAD HOC NEWS · 9/4/2026
- Centene Corp. stock gains on stronger earnings outlook and consensus upgradesAD HOC NEWS · 9/3/2026
- Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?TradingView · 9/2/2026
- Centene Corp stock reacts as margins and Marketplace recovery support guidanceAD HOC NEWS · 9/2/2026
- Centene Corp stock gains on stronger margins and Marketplace recoveryAD HOC NEWS · 9/1/2026
- Centene (NYSE:CNC) Remains Cheap Despite A Sharp RecoveryKalkine Media · 9/1/2026
- Centene stock gets support from analyst upgrades and strong earningsAD HOC NEWS · 8/31/2026
- Centene stock holds gains after strong Q2 and higher 2026 outlookAD HOC NEWS · 8/29/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.